Gastrointestinal cancers in the era of theranostics: Updates and future perspectives

World J Gastroenterol. 2015 Jul 28;21(28):8473-7. doi: 10.3748/wjg.v21.i28.8473.

Abstract

Theranostics are one of the practical aspects of personalized medicine. This concept was designed to describe a material combining diagnosis, treatment and follow up of a disease. It evolved and included molecular targeting and nanotechnologies that incorporate both diagnosis and therapeutics. In this editorial, we are presenting briefly the concept and evolution of theranostics, highlighting many applications of theranostics in daily practice and discussing future perspectives and aspects of this model in gastro-intestincal cancers.

Keywords: Gastrointestinal cancer; Molecular targeting; Nanoparticles; Nanotheranostics; Theranostics.

Publication types

  • Editorial
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Diffusion of Innovation
  • Forecasting
  • Gastrointestinal Neoplasms / diagnosis*
  • Gastrointestinal Neoplasms / genetics
  • Gastrointestinal Neoplasms / metabolism
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / therapy*
  • Genetic Predisposition to Disease
  • Humans
  • Molecular Diagnostic Techniques
  • Molecular Targeted Therapy
  • Phenotype
  • Predictive Value of Tests
  • Theranostic Nanomedicine* / trends
  • Treatment Outcome

Substances

  • Biomarkers, Tumor